FDA溶出度方法库2730条
药品名称
剂型
USP溶出方法
转速（转/min）
溶出介质
容积
荐采样时间
更新时间
Aspirin/Hydrocodone Bitartrate
Tablet
II (Paddle)
75
Acetate Buffer, pH 4.5
900
10, 20, 30, 45, 60 and 90
01/15/2004
Aspirin/Meprobamate
Tablet
I (Basket)
100
Water (deaerated)
900
10, 20, 30, 45, 60 and 90
01/15/2004
Aspirin/Methocarbamol
Tablet
II (Paddle)
50
Water (deaerated)
900
10, 20, 30, 45, 60 and 90
01/15/2004
Aspirin/Oxycodone HCl
Tablet
Refer to USP
01/15/2010
Atazanavir Sulfate
Capsule
II (Paddle)
50
0.025 N HCl
1000
10, 20, 30 and 45
01/20/2006
Atazanavir Sulfate/ Cobicistat
Tablet
II (Paddle)
75
0.05 M Citrate Buffer (pH 2.8)
1000
Atazanavir: 10, 15, 20, 30 and 45; Cobicistat: 5, 10, 15, 20 and 30
12/24/2015
Atenolol
Tablet
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Atenolol/Chlorthalidone
Tablet
Refer to USP
02/14/2014
Atomoxetine HCl
Capsule
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Atorvastatin Calcium
Tablet
II (Paddle)
75
0.05 M Phosphate buffer, pH 6.8
900
5, 10, 15 and 30
01/15/2004
Atorvastatin Calcium/Ezetimibe
Tablet
II (Paddle), with option to use a sinker for 20/10 mg strength
75
Phosphate buffer, pH 6.8 with 0.2% w/v Tween 80
900
5, 10, 15, 20, 30 and 45
05/15/2014
Atovaquone
Oral Suspension
Develop a dissolution method
07/21/2009
Atovaquone
Tablet
II (Paddle)
50
40% isopropanol buffered to pH 8.0 with potassium dihydrogen phosphate
900
10, 20, 30, 45, 60 and 90
06/18/2007
Atovaquone/Proguanil HCl
Tablet
II (Paddle) with PEAK vessels
50
40% isopropranol buffered to pH 8.0 with potassium dihydrogen phosphate
900
15, 30, 45 and 60
08/17/2006
Atropine Sulfate/ Diphenoxylate HCl
Tablet
Develop dissolution method(s) to characterize the dissolution of both components
12/22/2016
Auranofin
Capsule
II (Paddle)
50
Water (deaerated)
900
10, 20, 30, and 45
01/15/2004
Avanafil
Tablet
II (Paddle)
50
Simulated gastric fluid without pepsin.
900
5, 10, 15, 20 and 30
04/02/2015
Axitinib
Tablet
II (Paddle)
75
0.01 N HCl
900
5, 15, 30, 45 and 60
08/14/2014
Azacitidine
Injectable Suspension
Develop a dissolution method
09/03/2008
Azathioprine
Tablet
Refer to USP
04/08/2010